Castle Labs Reports $13.7 Billion in Revenue from Crypto Protocols Over the Past Year
Crypto research firm Castle Labs has released a report indicating that crypto protocols generated approximately $13.7 billion in revenue over the past 12 months. Excluding stablecoin issuers, the top 10 protocols contributed 47% of the protocol revenue and accounted for 73% of token holder earnings. The top two protocols in each sub-sector captured at least 52% of the fee revenue, with some sectors exceeding 90%. The decentralized perpetual contract trading platform Hyperliquid generated an annualized fee revenue of about $895 million, while the decentralized trading protocol Uniswap accounted for nearly 25% of the 30-day spot DEX trading volume. Despite the high concentration of protocol revenue, the leading tokens in most sectors still underperformed compared to Bitcoin. The report notes that protocol revenue does not necessarily translate into token holder earnings, as token performance also depends on value capture mechanisms, token issuance, future market space, and market narratives.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.
You may also like

Plaintiffs Request Sanctions Against Meta, Claiming About 93% of Reviewed Documents Were Improperly Withheld

Elon Musk Wants Jensen Huang Back at Nvidia. Here’s What’s at Stake for SpaceX

Tesla Plans to Invest €3 Billion to Expand Berlin Factory, Aiming for Annual Production of 1 Million Cybercabs

Former OpenAI Researcher Aschenbrenner's Hedge Fund Bets on AI Again Before October Market Crash

Tradeweb Launches AI Assistant for U.S. Treasury Traders, Over Ten Companies Testing

NYSE Parent Company Considers Operating Solana Validators

These 3 Dividend Stocks Have Crushed the Market This Year. Here’s Why They Are Still Buys

Aave’s revenue falls $10M in Q3, but one metric tells a new story

4 Chip Stocks Down as Much as 36% From Their Highs to Buy and Hold for the Next Decade

Unocoin Estimates $200,000 Loss as Backup-Key Finding Explains Wallet Transfers

Strategy planned to slow STRC buybacks near $100 but spent another $1.4 billion instead

Michael Burry Cashed In Caterpillar Puts After a Nearly 4x Gain Even as CAT Stock Fell 10% in Its Worst Week in 18 Months. Is Caterpillar Still Overvalued, or Did Burry Just Lock In the Easy Money?

CoinShares Enters Russell Index Review as Crypto Stocks Seek Broader Investor Access

ARTEX AI tool breaches networks in under 3 hours, FBI warns

Tether invests $15M in Nomad as Brazil tightens payment rules

XRP’s proposed upgrade could improve trading without boosting token demand

Nike's Turnaround Is Taking Longer Than Expected. These 3 Stocks May Be Better Buys.

Clarity Act Defeat ‘Failure of American Leadership’: Trump’s Former Crypto Chief

TRON to overtake JD.com? Justin Sun points to 500-person team

Where Will Eli Lilly Be in 10 Years? 1 Clue: Its Next Potential Blockbuster Just Beat Ozempic Head-to-Head

3 Financial Stocks to Buy and Hold That Turned $1,000 Into More Than $5,000 Over the Past Decade, Counting Dividends

William Shatner disowns QUATS token and calls charity pitch a scam

Taiwan stablecoin draft puts banks in control of new issuers

Retail Sales and Fed Minutes Put Bitcoin’s Rate Outlook Back in Focus

Santiago Bausili acknowledged that stability is not enough for growth

$LIBRA: One of the defendants seeks to remove Judge Ledesma and halt the review that could reactivate the case

'Tokenization Is Not the Finish Line': Jupiter to Let Users Borrow Against Bullish Shares

Anthropic's Wall Street Operator: CFO Krišna Rao

Novo Nordisk Clinical Trial Shows: Wegovy Injection Reduces BMI and Obesity Rates in Children



